Viewing Study NCT02993094


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-02-22 @ 6:43 PM
Study NCT ID: NCT02993094
Status: TERMINATED
Last Update Posted: 2020-11-30
First Post: 2016-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: AGMT_MBC-10 (X16087)
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View